CuoripsCuorips Inc.4894東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP
Cuorips brought in ¥175.2M in revenue.
It lost about ¥337 for every ¥100 of sales at the operating level.
Revenue changed +658.4% from the prior year.
FY ending Mar 2024 → FY ending Mar 2025
FY ending Mar 2024 → FY ending Mar 2025
For every ¥100 Cuorips sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書-第10期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
有価証券報告書-第9期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第8期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第7期(2022/04/01-2023/03/31)
Extracted from XBRL: 44 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.